Association of HLA-Bw35 with mucocutaneous lesions in rheumatoid arthritis patients undergoing sodium aurothiomalate therapy.
D000328:Adult; D000368:Aged; D001172:Arthritis, Rheumatoid / Q000150:complications* / Q000188:drug therapy; D005260:Female; D006052:Gold Sodium Thiomalate / Q000009:adverse effects*; D006680:HLA Antigens / Q000032:analysis*; D015797:HLA-B35 Antigen; D006801:Humans; D008297:Male; D008875:Middle Aged; D010641:Phenotype; D012871:Skin Diseases / Q000139:chemically induced / Q000150:complications* / Q000276:immunology
D006680:HLA Antigens; D015797:HLA-B35 Antigen; D006052:Gold Sodium Thiomalate